Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


New anti-malaria drug


The malaria parasite multiplies in red blood cells, safe from our immune defences

Monkey tests hint compound could paralyse malaria parasite in humans.

A new-found chemical can root out malaria parasites hiding in red blood cells and stop them reproducing. It may become a much-needed new weapon in the war against one of the world’s biggest killers.

The compound clears monkeys of infection with the human malaria parasite Plasmodium falciparum at doses far lower than existing antimalarial drugs. But testing in humans is a few years away at least, says Henri Vial at Montpellier University in France who discovered the 1.

Developing new antimalarials is essential: malaria kills more than one million people each year, and the parasites are becoming resistant to existing drugs.

Malaria parasites enter our blood when the mosquitoes that carry them bite us. The parasites multiply inside red blood cells, safe from the body’s immune system.

Vial’s team developed a range of compounds that interfere with the building of cell membranes. Rapidly reproducing parasites are constantly making new cell membranes.

They used infected human blood samples to screen all their chemicals for antimalarial activity. A compound with the working name G25 came out on top.

"We were very lucky," says Vial: G25 only enters red-blood cells that harbour reproducing malaria parasites. Why is a mystery, and "the focus of our research now", Vial says.

This selectivity is important for two reasons. First, because all animal cells make membranes, G25 would be highly toxic if it were less discerning. More importantly, scientists could exploit the chemical’s nose for malaria-infected cells to deliver other antimalarial compounds. "It is a natural targeting mechanism," Vial says.

"No other group of drugs works like this," says Peter Winstanley, who is developing new antimalarial drugs at the University of Liverpool in England. As a result, he hopes G25 could kill even drug-resistant malaria.

But because G25 acts on a fundamental biological system there could be harmful side-effects. Vial’s team saw nothing untoward in monkeys, but admits more work on the safety of the compound is needed.

Another big hurdle is getting the compound into pill form. Currently it has to be injected. "We do have problems with oral absorption," says Vial. Chemical tweaking of G25 should help.

Scientific obstacles aside, new malaria drugs face an uphill economic struggle, cautions Winstanley. To save the most lives, malaria drugs must be affordable for developing countries where the disease is endemic. Keeping development costs low enough to achieve this is hard.

The newest antimalarial drug on the market costs $57 for a course of treatment. For the developing world "it would need to cost a lot less than 50 cents", Winstanley says.


  1. Wengelnik, K. et al. A class of potent antimalarials and their specific accumulation on infected erythrocytes. Science, 295, 1311 - 1314, (2002).

TOM CLARKE | © Nature News Service
Further information:

More articles from Health and Medicine:

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

nachricht Breakthrough in Mapping Nicotine Addiction Could Help Researchers Improve Treatment
04.10.2016 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Novel mechanisms of action discovered for the skin cancer medication Imiquimod

21.10.2016 | Life Sciences

Second research flight into zero gravity

21.10.2016 | Life Sciences

How Does Friendly Fire Happen in the Pancreas?

21.10.2016 | Life Sciences

More VideoLinks >>>